Authors: Demarquay, D Huchet, M Coulomb, H Lesueur-Ginot, L Lavergne, O Kasprzyk, PG Bailly, C Camara, J Bigg, DCH

Citation: D. Demarquay et al., The homocamptothecin BN 80915 is a highly potent orally active topoisomerase I poison, ANTI-CANC D, 12(1), 2001, pp. 9-19

Authors: Lavergne, O Demarquay, D Bailly, C Lanco, C Rolland, A Huchet, M Coulomb, H Muller, N Baroggi, N Camara, J Le Breton, C Manginot, E Cazaux, JB Bigg, DCH

Citation: O. Lavergne et al., Topoisomerase I-mediated antiproliferative activity of enantiomerically pure fluorinated homocamptothecins, J MED CHEM, 43(11), 2000, pp. 2285-2289

Authors: Lavergne, O Harnett, J Rolland, A Lanco, C Lesueur-Ginot, L Demarquay, D Huchet, M Coulomb, H Bigg, DCH

Citation: O. Lavergne et al., BN 80927: A novel homocamptothecin with inhibitory activities on both topoisomerase I and topoisomerase II, BIOORG MED, 9(17), 1999, pp. 2599-2602

Authors: Bailly, C Lansiaux, A Dassonneville, L Demarquay, D Coulomb, H Huchet, M Lavergne, O Bigg, DCH

Citation: C. Bailly et al., Homocamptothecin, an E-ring-modified camptothecin analogue, generates new topoisomerase I-mediated DNA breaks, BIOCHEM, 38(47), 1999, pp. 15556-15563